Craig A Clifford, DVM, MS, DACVIM (Oncology) talks about the most common bladder tumor in dogs, misdiagnosis, and the Cadet ...

CNX Therapeutics Limited (“CNX Therapeutics”), a leading European specialty pharmaceutical company, has today announced an exclusive partnership with Adalvo to commercialise a prolonged release ...

L1-blocking antibody is now approved for metastatic or locally advanced cutaneous SCC in adults who are not candidates for curative surgery or curative radiation.

The most common adverse reactions reported with treatment were fatigue, musculoskeletal pain, rash, diarrhea, hypothyroidism, constipation, nausea, headache, pruritus, edema, localized infection, and ...

Orlando Urology Associates Albert Ong, MD; Stephen Baker, MD; Marshall Melcer, MD; Jorge Rivera Mirabal, MD ANNOUNCEMENT The ...

Not only does the winter season see a spike in joint issues, respiratory illnesses, urinary tract infections (UTIs), and skin ...

Type 2 diabetes is a chronic condition where the body becomes resistant to insulin or doesn't produce enough of it, leading ...

So, treatment options range from dietary changes and increased fluid intake to ... in the body leading to the formation of ...

Cilantro, otherwise known as coriander, is a herb commonly used in hundreds of dishes across cultures worldwide. It can be a ...

Doctors have taken to social media to share seven symptoms of bladder cancer – the 11th most common cancer in the UK – ...

Larry Antonucci, M.D., MBA is the president & CEO of Lee Health, Southwest Florida’s major destination for health care ...

The medication needs to be injected as a 60-minute infusion every three weeks ... reactions where the needle went in, and urinary tract infections. Checkpoint Therapeutics, the maker of Unloxcyt, ...